tiprankstipranks
Trending News
More News >
Sensei Biotherapeutics (SNSE)
NASDAQ:SNSE
US Market

Sensei Biotherapeutics (SNSE) Cash flow

Compare
221 Followers

Sensei Biotherapeutics Cash Flow

SNSE's free cash flow for Q3 2025 was $-3.59M. For the 2025 fiscal year, SNSE's free cash flow was decreased by $7.39M and operating cash flow was $-3.59M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -24.67M$ -32.02M$ -39.03M$ -30.26M$ -17.70M
Investing Cash Flow
$ 22.44M$ 38.41M$ 49.95M$ -143.12M$ -1.40M
Financing Cash Flow
$ -787.00K$ -11.17M$ -287.00K$ 163.94M$ 35.45M
End Cash Position
$ 9.99M$ 13.01M$ 17.80M$ 7.16M$ 16.60M
Free Cash Flow
$ -24.82M$ -32.20M$ -39.35M$ -32.28M$ -18.91M
Currency in USD

Sensei Biotherapeutics Cash Flow